Chronic pain is highly prevalent. Current management is challenged by lack of validated objective measures like biological markers. Clinical pain studies employing exercise interventions have evaluated biomarkers; however, it is unclear how exercise impacts biomarkers involved in pain pathways and whether these markers are associated with relevant pain-related outcomes. This systematic review evaluates data from clinical studies employing exercise interventions in chronic musculoskeletal nonmalignant pain conditions in which biomarkers in pain pathways were measured.
Method:
Published research studies from several databases were examined using the Jadad Scale for assessing the quality of clinical studies.
Results:
Twelve research studies were reviewed. Jadad scores ranged from 5 to 11 out of 13 points. Inflammatory markers were most commonly measured followed by neurotransmitter-related genes and metabolite-detecting genes. After exercise interventions, changes in biomarkers involved in neurotransmission and inflammation suggest a hypoalgesic exercise effect. Significant biomarker associations were found with pain intensity, fatigue, depression, anxiety, and quality of life. However, there were varying methodologies in the studies reviewed.
Discussion:
It remains a question whether biomarkers can be used as objective measures for risk assessment, diagnosis, or evaluation or as surrogate endpoints in chronic pain. Adequate sample sizes, optimal exercise dose determination, study replications, and longitudinal research studies with consistent methodologies are warranted. Regardless, the potential translational value of biomarkers in chronic pain is evident. Advancing nursing research in biomarkers is vital for moving the nursing discipline and clinical chronic pain practice forward. Developing a biobehavioral perspective in chronic pain is also necessary for comprehensive management.
BelferI.SegallS. (2011). COMT genetic variants and pain. Drugs of Today, 47, 457–467.
2.
BorsookD.BecerraL.HargreavesR. (2011). Biomarkers for chronic pain and analgesia. Part 1: The need, reality, challenges, and solutions. Discovery Medicine, 11, 197–207.
3.
BoteM. E.GarciaJ. J.HinchadoM. D.OrtegaE. (2013). Fibromyalgia: Anti-inflammatory and stress responses after acute moderate exercise. PLoS One, 8, e74524.
4.
BroxJ. I.SorensenR.FriisA.NygaardO.IndahlA.KellerA.…ReikerasO. (2003). Randomized clinical trial of lumbar instrumented fusion and cognitive intervention and exercises in patients with chronic low back pain and disc degeneration. Spine, 28, 1913–1921.
5.
CalzoneK. A.CashionA.FeethamS.JenkinsJ.ProwsC. A.WilliamsJ. K.…WungS.-F. (2010). Nurses transforming health care using genetics and genomics. Nursing Outlook, 58, 26–35.
6.
CalzoneK. A.JenkinsJ.BakosA. D.CashionA. K.DonaldsonN.Gregory FeeroW.…WebbJ. A. (2013). A blueprint for genomic nursing science. Journal of Nursing Scholarship, 45, 96–104.
7.
ChouR.HuffmanL. H. (2007). Nonpharmacologic therapies for acute and chronic low back pain: A review of the evidence for an American pain society/American college of physicians clinical practice guideline. Annals of Internal Medicine, 147, 492–504.
8.
DiatchenkoL.SmithS. B.MaixnerW. (2014). Translating genetic knowledge into clinical practice for musculoskeletal pain conditions. In BelferI.DiatchenkoL. (Eds.), Pain genetics: Basic to translational science (pp. 147–159). Ames, IA: John Wiley.
9.
FinstererJ. (2012). Biomarkers of peripheral muscle fatigue during exercise. BMC Musculoskeletal Disorders, 13, 218.
10.
FoulkesT.WoodJ. N. (2008). Pain genes. PLoS Genetics, 4, e1000086.
11.
GaskinD. J.RichardP. (2012). The economic costs of pain in the United States. Journal of Pain, 13, 715–724.
12.
GeneraalE.VogelzangsN.MacfarlaneG. J.GeenenR.SmitJ. H.DekkerJ.PenninxB. W. (2014). Basal inflammation and innate immune response in chronic multisite musculoskeletal pain. Pain, 155, 1605–1612.
13.
GeorgeS. Z.DoverG. C.WallaceM. R.SackB. K.HerbstmanD. M.AydogE.FillingimR. B. (2008). Biopsychosocial influence on exercise-induced delayed onset muscle soreness at the shoulder: Pain catastrophizing and catechol-O-methyltransferase (COMT) diplotype predict pain ratings. Clinical Journal of Pain, 24, 793–801.
14.
HockingL. J.MorrisA. D.DominiczakA. F.PorteousD. J.SmithB. H. (2012). Heritability of chronic pain in 2195 extended families. European Journal of Pain, 16, 1053–1063.
15.
HootenW. M.TimmingR.BelgradeM.GaulJ.GoertzM.HaakeB.…WalkerN. (2013). Assessment and management of chronic pain. Bloomington, MN: Institute for Clinical Systems Improvement. Retrieved fromhttp://www.guideline.gov/content.aspx?id=47646
JadadA. R.MooreR. A.CarrollD.JenkinsonC.ReynoldsD. J.GavaghanD. J.McQuayH. J. (1996). Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 17, 1–12.
18.
JainK. K. (2010). The handbook of biomarkers. New York, NY: Springer.
19.
JamesS. (2013). Human pain and genetics: Some basics. British Journal of Pain, 7, 171–178.
20.
KawabataA. (2011a). Lipid mediators and pain signaling. Foreword. Biological and Pharmaceutical Bulletin, 34, 1153.
21.
KawabataA. (2011b). Prostaglandin E2 and pain—An update. Biological and Pharmaceutical Bulletin, 34, 1170–1173.
22.
KhanJ.BenaventV.KorczeniewskaO. A.BenolielR.EliavE. (2014). Exercise-induced hypoalgesia profile in rats predicts neuropathic pain intensity induced by sciatic nerve constriction injury. Journal of Pain, 15, 1179–1189.
23.
KimD. H.SchwartzC. E. (2010). The genetics of pain: Implications for evaluation and treatment of spinal disease. Spine Journal, 10, 827–840.
24.
KimH.ClarkD.DionneR. A. (2009). Genetic contributions to clinical pain and analgesia: Avoiding pitfalls in genetic research. Journal of Pain, 10, 663–693.
KimH.NeubertJ. K.San MiguelA.XuK.KrishnarajuR. K.IadarolaM. J.…DionneR. A. (2004). Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain, 109, 488–496.
27.
LightA. R.BatemanL.JoD.HughenR. W.VanhaitsmaT. A.WhiteA. T.LightK. C. (2012). Gene expression alterations at baseline and following moderate exercise in patients with chronic fatigue syndrome and fibromyalgia syndrome. Journal of Internal Medicine, 271, 64–81.
28.
LightA. R.WhiteA. T.HughenR. W.LightK. C. (2009). Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. Journal of Pain, 10, 1099–1112.
29.
MessierS. P.MihalkoS. L.LegaultC.MillerG. D.NicklasB. J.DeVitaP.…LoeserR. F. (2013). Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: The IDEA randomized clinical trial. Journal of the American Medical Association, 310, 1263–1273.
30.
MunroC. L. (2015). Individual genetic and genomic variation: A new opportunity for personalized nursing interventions. Journal of Advanced Nursing, 71, 35–41.
31.
NaugleK. M.FillingimR. B.RileyJ. L. (3rd Ed (2012). A meta-analytic review of the hypoalgesic effects of exercise. Journal of Pain, 13, 1139–1150.
32.
OlivoS. A.MacedoL. G.GadottiI. C.FuentesJ.StantonT.MageeD. J. (2008). Scales to assess the quality of randomized controlled trials: A systematic review. Physical Therapy, 88, 156–175.
33.
OmairA.HoldenM.LieB. A.ReikerasO.BroxJ. I. (2013). Treatment outcome of chronic low back pain and radiographic lumbar disc degeneration are associated with inflammatory and matrix degrading gene variants: A prospective genetic association study. BMC Musculoskeletal Disorders, 14, 105.
34.
OmairA.LieB. A.ReikerasO.HoldenM.BroxJ. I. (2012). Genetic contribution of catechol-O-methyltransferase variants in treatment outcome of low back pain: A prospective genetic association study. BMC Musculoskeletal Disorders, 13, 76.
35.
OrtegaE.BoteM. E.GiraldoE.GarciaJ. J. (2012). Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients. Scandinavian Journal of Medicine and Science in Sports, 22, 104–112.
36.
OrtegaE.GarciaJ. J.BoteM. E.Martin-CorderoL.EscalanteY.SaavedraJ. M.…GiraldoE. (2009). Exercise in fibromyalgia and related inflammatory disorders: Known effects and unknown chances. Exercise Immunology Review, 15, 42–65.
37.
ParrJ.FillingimR.WallaceM.WuS.BorsaP.GeorgeS. (2013). Catechol-O-methyltransferase and psychological interactions predict exercise induced muscle pain phenotypes. Journal of Pain, 14, S98.
38.
PedersonB. K. (2000). Exercise and cytokines. Immunology and Cell Biology, 78, 532–535.
39.
SchillerJ. S.LucasJ. W.WardB. W.PeregoyJ. A. (2012). Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Statistics, 10, 1–207.
40.
ShehataM.SchwarzmeierJ. D.HilgarthM.DemirtasD.RichterD.HubmannR.…FalkenbachA. (2006). Effect of combined spa-exercise therapy on circulating TGF-beta1 levels in patients with ankylosing spondylitis. Wiener Klinische Wochenschrift, 118, 266–272.
41.
SimãoA. P.AvelarN. C.Tossige-GomesR.NevesC. D.MendoncaV. A.MirandaA. S.…LacerdaA. C. (2012). Functional performance and inflammatory cytokines after squat exercises and whole-body vibration in elderly individuals with knee osteoarthritis. Archives of Physical Medicine and Rehabilitation, 93, 1692–1700.
42.
TegederI.LotschJ. (2009). Current evidence for a modulation of low back pain by human genetic variants. Journal of Cellular and Molecular Medicine, 13, 1605–1619.
43.
ÜçeylerN.HäuserW.SommerC. (2011). Systematic review with meta-analysis: Cytokines in fibromyalgia syndrome. BMC Musculoskeletal Disorders, 12, 245.
44.
Vargas-AlarcónG.FragosoJ. M.Cruz-RoblesD.VargasA.VargasA.Lao-VilladónigaJ. I.…Martínez-LavínM. (2007). Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Research & Therapy, 9, R110.
45.
WangD.KimH.WangX. M.DionneR. (2012). Genomic methods for clinical and translational pain research. Methods in Molecular Biology, 851, 9–46.
46.
WhiteA. T.LightA. R.HughenR. W.BatemanL.MartinsT. B.HillH. R.LightK. C. (2010). Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology, 47, 615–624.
47.
WhiteA. T.LightA. R.HughenR. W.VanhaitsmaT. A.LightK. C. (2012). Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls. Psychosomatic Medicine, 74, 46–54.
48.
YoungE. E.LariviereW. R.BelferI. (2012). Genetic basis of pain variability: Recent advances. Journal of Medical Genetics, 49, 1–9.
